Extended Data Fig. 8: HPLC-HR-MS analysis of cell wall esterified non-decarboxylated diFA from 6-[2H3]-P3, [2H3]-FA treatment groups and control.
From: A sucrose ferulate cycle linchpin for feruloylation of arabinoxylans in plant commelinids
![Extended Data Fig. 8: HPLC-HR-MS analysis of cell wall esterified non-decarboxylated diFA from 6-[2H3]-P3, [2H3]-FA treatment groups and control.](http://media.springernature.com/full/springer-static/esm/art%3A10.1038%2Fs41477-024-01781-1/MediaObjects/41477_2024_1781_Fig13_ESM.jpg?as=webp)
a, EIC of non-decarboxylated diFA (385.0918, C20H17O8, [M-H]-). a-k refers to non-decarboxylated diFA. b, EIC of [2H3]-non-decarboxylated diFA (388.1106, C20H14D3O8, [M-H]-). a-i: EIC from treatment groups compared to control. 1: control; 2: 6.95 μM 6-[2H3]-P3 treatment group; 3: 6.95 μM [2H3]-FA treatment group. Ion chromatogram marked red is selected to show the observed mass spectra of non-decarboxylated diFA and [2H3]-non-decarboxylated diFA from the control and the treatment groups (c). c, Mass spectra of non-decarboxylated diFA (Calcd. of C20H17O8 is 385.0918, [M-H]-), and [2H3]-non-decarboxylated diFA (Calcd. of C20H14D3O8 is 388.1106, [M-H]-) from control and 6.95 μM 6-[2H3]-P3, 6.95 μM [2H3]-FA treatment groups.
